He was transferred to [**Hospital1 18**] for evaluation of possible stroke and management of hyperglycemia.
After MRI/A showed no evidence of a stroke, the patient was transferred to the MICU for further management of DKA and rhabdomyolosis.
In the MICU, the patient was aggressively hydrated for treatment of DKA and rhabdomyolysis.
Given concern for infected foot ulcers, he was started on Vanco/Unasyn.
Off psych meds x several years.
Was on Amiodarone in the past.
Positive PPD, treated with INH in [**2157**].
Pertinent Results: [**2166-6-26**] 12:04PM   WBC-15.1*# RBC-5.28# HGB-15.3# HCT-47.3# MCV-90 MCH-29.1 MCHC-32.5 RDW-13.7 [**2166-6-26**] 12:04PM   PLT COUNT-290 [**2166-6-26**] 12:04PM   GLUCOSE-443* UREA N-35* CREAT-1.5* SODIUM-140 POTASSIUM-4.4 CHLORIDE-100 TOTAL CO2-22 ANION GAP-22* [**2166-6-26**] 01:25PM URINE  BLOOD-LG NITRITE-NEG PROTEIN-30 GLUCOSE-1000 KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2166-6-26**] 01:25PM URINE  RBC-0 WBC-1 BACTERIA-RARE YEAST-NONE EPI-0 [**2166-6-26**] 01:25PM URINE  bnzodzpn-NEG barbitrt-NEG opiates-NEG cocaine-NEG amphetmn-NEG mthdone-NEG [**2166-6-26**] 01:38PM   CK(CPK)-[**Numeric Identifier 23302**]*  [**6-29**] Lab Data: Hematology  WBC RBC Hgb Hct MCV MCH MCHC RDW Plt Ct 13.2* 3.65* 10.6* 32.3* 89 29.2 32.9 14.7 310 Chemistry RENAL & GLUCOSE Glucose UreaN Creat Na K Cl HCO3 AnGap [**2166-6-29**] 06:36AM    131* 31* 1.4* 149* 3.7 113* 27 13 ENZYMES & BILIRUBIN ALT AST LD(LDH) CK(CPK) AlkPhos Amylase TotBili DirBili [**2166-6-29**] 06:36AM    134* 292* 525*   388* 228* 1.5 OTHER ENZYMES & BILIRUBINS Lipase     [**2166-6-29**] 06:36AM    141* CHEMISTRY TotProt Albumin Globuln Calcium Phos Mg UricAcd Iron [**2166-6-29**] 06:36AM      2.6*   8.1* 2.8 2.0  Micro data: Blood cx [**6-27**]: NGTD Urine cx [**6-27**]: NG [**2166-6-27**] 12:13 am SWAB     Site: ANKLE      Source: left ankle decub.
RADIOLOGY  Final Report  CHEST (PORTABLE AP)  [**2166-6-26**] 11:57 AM  CHEST (PORTABLE AP)  Reason: [**Month (only) **] BS - eval for infil  [**Hospital 93**] MEDICAL CONDITION: 83 year old man with REASON FOR THIS EXAMINATION: [**Month (only) **] BS - eval for infil INDICATION: Decreased breath sounds.
DR. [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern4) 23304**] DR. [**First Name (STitle) 8085**] [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 8086**] Approved: FRI [**2166-7-4**] 9:58 AM  Brief Hospital Course: A/P: 83 yo M with PMH of mental retardation, bipolar disorder, and diabetes mellitus, admitted on [**6-26**] with DKA, rhabdomyolysis, and new onset R hemiplegia.
1) DM: Pt initially admitted to MICU for management of DKA.
FS BS improved during the course of the hospitalization with titration of his NPH and institution of a regular insulin sliding scale.
He may still benefit from further titration of his NPH at his nursing home.
The Neurology team initially believed that R hemiparesis was related to patient's hyperglycemia.
LFTs have been trending downward since discontinuation of Unasyn (see below).
The patient was initially placed on Unasyn and Vancomycin, and subsequently changed to Levofloxacin and Oxacillin.
On [**7-2**], all antibiotics were discontinued since ulcers did not appear to be infected.
6) HTN: BP meds held in ICU.
On [**7-1**], the patient's outpatient medications,  Lasix and HCTZ, were restarted.
The patient will be treated with Lovenox 80 mg SC q 12 hrs x 4 weeks.
9) Prophylaxis: The patient was maintained on subcutaneous heparin.
Medications on Admission: Glipizide 5 mg qd HCTZ 25 mg  qd KCL 10 mEq qd Lasix 20 mg qd Vit C 500 mg [**Hospital1 **] ASA 325 mg qd MVI 1 tab qd RISS Arginaid [**Hospital1 **]  Discharge Medications: 1.
Hydrocortisone 1 % Cream Sig: One (1) Appl Topical  QID (4 times a day).
Hydrochlorothiazide 25 mg Tablet Sig: One (1) Tablet PO QD (once a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO QD (once a day).
Dipyridamole-Aspirin 200-25 mg Capsule, Multiphasic Release Sig: One (1) Cap PO BID (2 times a day).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Glipizide 5 mg Tablet Sig: One (1) Tablet PO QD (once a day).
Insulin Regular Human 100 unit/mL Solution Sig: One (1) Injection every six (6) hours: Regular insulin sliding scale.
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: Fifteen (15) units Subcutaneous qAM.
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: Eight (8) units Subcutaneous at bedtime.
The patient may need further titration of his NPH for optimal blood glucose control.
